DSpace Arşivi :: by Yazar "Kneba, Michael" değerine göre listeleniyor

Listeleniyor 1 - 2 / 2

Modified IPCW model: A method for adjusting for bias in the estimation of overall survival due to the use of second and third line therapies in locally advanced or metastatic pancreatic cancer patients.
(Amer Soc Clinical Oncology, 2017) Escobar, N. E. Iznaga; Luaces, Patricia Lorenzo; Valdes, Lizet Sanchez; Silva, Carmen Valenzuela; Ramos, Tania Crombet; Strumberg, Dirk; Schultheis, Beate; Ebert, Matthias Philip; Kerkhoff, Andrea; Hofheinz, Ralf; Behringer, Dirk M.; Schmidt, Wolfgang E.; Goker, Erdem; De Doss, Sara; Kneba, Michael; Yalcin, Suayib; Overkamp, Friedrich; Schlegel, Frank; Markus
Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC)
(Amer Soc Clinical Oncology, 2013) Strumberg, Dirk; Schultheis, Beate; Ebert, Matthias Philip; Kerkhoff, A.; Hofheinz, Ralf Dieter; Behringer, Dirk M.; Schmidt, Wolfgang E.; Goker, Erdem; De Dosso, Sara; Kneba, Michael; Yalcin, Suayib; Overkamp, Friedrich; Schlegel, Frank; Dommach, M.; Rohrberg, Robert; Steinmetz, Tilman; Reuter, Dirk; Bach, Ferdinand